Tapewire

Nasdaq · USD

TBPH

Theravance Biopharma, Inc.

Export transactions ↓
Tapewire entity
5037
SEC CIK
0001583107
Parsed reports
533

Last 12 months

Inside the activity.

0 purchase rows · 25 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202508
Dec 202503
Jan 202600
Feb 202600
Mar 202603
Apr 202600
May 202600
Jun 202605
Jul 202603
Aug 202600
Sep 202603
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 20, 2025 Filed May 22, 2025 22:42 UTC
Sawaf AzizSVP & CHIEF FINANCIAL OFFICER
Tax withholdingOrdinary Shares 9,348 $9.45 $88,338.60
Disclosure

SEC source: 0001415889-25-014261 · form4-05222025_100548.xml · nonDerivative · entry 1

Sawaf Aziz · CIK 0001961289 · SVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 364,790

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
May 19, 2025 Filed May 21, 2025 23:22 UTC
Miller AineSVP, DEV & HEAD OF IRE OFFICE
GrantOrdinary Shares 10,430 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-014025 · form4-05212025_110558.xml · nonDerivative · entry 1

Miller Aine · CIK 0002012524 · SVP, DEV & HEAD OF IRE OFFICE

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 224,691

F1 · shares: On April 2, 2024 the reporting person was granted a performance restricted stock unit award that vests based on the achievement of certain performance conditions and continued employment. On May 19, 2025, the performance conditions were deemed achieved as to 10,430 RSUs, and such RSUs are eligible to vest based on the reporting person's continued service.

Read SEC document
May 19, 2025 Filed May 21, 2025 19:10 UTC GrantShare Option (Right to Buy) · Derivative 24,258 $0.00 Strike: $9.39 $0.00
Disclosure

SEC source: 0001415889-25-014005 · form4-05212025_110527.xml · derivative · entry 2

Grant Jeremy T · CIK 0002004368 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,258

Underlying: Ordinary Shares · 24,258 shares

Expires 2035-05-18

F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date.

Read SEC document
May 19, 2025 Filed May 21, 2025 19:10 UTC GrantOrdinary Shares 10,649 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-014005 · form4-05212025_110527.xml · nonDerivative · entry 1

Grant Jeremy T · CIK 0002004368 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,954

Read SEC document
May 19, 2025 Filed May 21, 2025 23:20 UTC GrantShare Option (Right to Buy) · Derivative 24,258 $0.00 Strike: $9.39 $0.00
Disclosure

SEC source: 0001415889-25-014022 · form4-05212025_110510.xml · derivative · entry 2

PAKIANATHAN DEEPIKA · CIK 0001270734 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,258

Underlying: Ordinary Shares · 24,258 shares

Expires 2035-05-18

F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date.

Read SEC document
May 19, 2025 Filed May 21, 2025 23:20 UTC GrantOrdinary Shares 10,649 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-014022 · form4-05212025_110510.xml · nonDerivative · entry 1

PAKIANATHAN DEEPIKA · CIK 0001270734 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,065

Read SEC document
May 19, 2025 Filed May 21, 2025 23:15 UTC GrantShare Option (Right to Buy) · Derivative 24,258 $0.00 Strike: $9.39 $0.00
Disclosure

SEC source: 0001415889-25-014015 · form4-05212025_110547.xml · derivative · entry 2

MITCHELL DEAN J · CIK 0001199297 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,258

Underlying: Ordinary Shares · 24,258 shares

Expires 2035-05-18

F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date.

Read SEC document
May 19, 2025 Filed May 21, 2025 23:15 UTC GrantOrdinary Shares 10,649 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-014015 · form4-05212025_110547.xml · nonDerivative · entry 1

MITCHELL DEAN J · CIK 0001199297 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,204

Read SEC document
May 19, 2025 Filed May 21, 2025 23:02 UTC
BROSHY ERANDirector
GrantShare Option (Right to Buy) · Derivative 24,258 $0.00 Strike: $9.39 $0.00
Disclosure

SEC source: 0001415889-25-014000 · form4-05212025_110551.xml · derivative · entry 2

BROSHY ERAN · CIK 0001256230 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,258

Underlying: Ordinary Shares · 24,258 shares

Expires 2035-05-18

F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date.

Read SEC document
May 19, 2025 Filed May 21, 2025 23:02 UTC
BROSHY ERANDirector
GrantOrdinary Shares 10,649 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-014000 · form4-05212025_110551.xml · nonDerivative · entry 1

BROSHY ERAN · CIK 0001256230 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,204

Read SEC document
May 19, 2025 Filed May 21, 2025 23:17 UTC GrantShare Option (Right to Buy) · Derivative 24,258 $0.00 Strike: $9.39 $0.00
Disclosure

SEC source: 0001415889-25-014017 · form4-05212025_110551.xml · derivative · entry 2

O'Connor Donal · CIK 0001625377 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,258

Underlying: Ordinary Shares · 24,258 shares

Expires 2035-05-18

F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date.

Read SEC document
May 19, 2025 Filed May 21, 2025 23:17 UTC GrantOrdinary Shares 10,649 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-014017 · form4-05212025_110551.xml · nonDerivative · entry 1

O'Connor Donal · CIK 0001625377 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,204

Read SEC document
May 19, 2025 Filed May 21, 2025 23:13 UTC GrantShare Option (Right to Buy) · Derivative 24,258 $0.00 Strike: $9.39 $0.00
Disclosure

SEC source: 0001415889-25-014009 · form4-05212025_110557.xml · derivative · entry 2

GRAY SUSANNAH · CIK 0001833453 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,258

Underlying: Ordinary Shares · 24,258 shares

Expires 2035-05-18

F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date.

Read SEC document
May 19, 2025 Filed May 21, 2025 23:13 UTC GrantOrdinary Shares 10,649 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-014009 · form4-05212025_110557.xml · nonDerivative · entry 1

GRAY SUSANNAH · CIK 0001833453 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,137

Read SEC document
May 19, 2025 Filed May 21, 2025 23:00 UTC GrantShare Option (Right to Buy) · Derivative 24,258 $0.00 Strike: $9.39 $0.00
Disclosure

SEC source: 0001415889-25-013997 · form4-05212025_110526.xml · derivative · entry 2

Smaldone Alsup Laurie · CIK 0001589602 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,258

Underlying: Ordinary Shares · 24,258 shares

Expires 2035-05-18

F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date.

Read SEC document
May 19, 2025 Filed May 21, 2025 23:00 UTC GrantOrdinary Shares 10,649 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-013997 · form4-05212025_110526.xml · nonDerivative · entry 1

Smaldone Alsup Laurie · CIK 0001589602 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,980

Read SEC document
April 21, 2025 Filed Apr 23, 2025 22:00 UTC
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
SaleOrdinary Shares 4,000 $9.00 $36,000.00
Disclosure

SEC source: 0001415889-25-011227 · form4-04232025_100431.xml · nonDerivative · entry 1

Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 370,038

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:09 UTC
Miller AineSVP, DEV & HEAD OF IRE OFFICE
GrantOrdinary Shares 75,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-006675 · form4-03042025_110312.xml · nonDerivative · entry 1

Miller Aine · CIK 0002012524 · SVP, DEV & HEAD OF IRE OFFICE

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 214,261

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:07 UTC
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY
GrantOrdinary Shares 75,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-006670 · form4-03042025_110315.xml · nonDerivative · entry 1

Grimaud Brett A. · CIK 0001966698 · SVP, GEN COUNSEL AND SECRETARY

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 393,811

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:05 UTC
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
GrantOrdinary Shares 75,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-006668 · form4-03042025_110355.xml · nonDerivative · entry 1

Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 374,038

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:17 UTC
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
GrantOrdinary Shares 2,178 $9.35 $20,364.30
Disclosure

SEC source: 0001415889-25-006684 · form4-03042025_110318.xml · nonDerivative · entry 1

Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,778,144

F1 · kind: Reflects an acquisition from the Issuer pursuant to a restricted share purchase agreement under the Issuer's Amended and Restated 2013 Equity Incentive Plan at a per-share price equal to the closing per-share price of the Issuer's ordinary shares on the Nasdaq Global Market on February 28, 2025.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 23:11 UTC
Sawaf AzizSVP & CHIEF FINANCIAL OFFICER
GrantOrdinary Shares 75,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-006679 · form4-03042025_110322.xml · nonDerivative · entry 1

Sawaf Aziz · CIK 0001961289 · SVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 374,138

Read SEC document
February 20, 2025 Filed Feb 25, 2025 00:28 UTC
Miller AineSVP, DEV & HEAD OF IRE OFFICE
Tax withholdingOrdinary Shares 11,295 $9.66 $109,109.70
Disclosure

SEC source: 0001415889-25-005351 · form4-02252025_120228.xml · nonDerivative · entry 1

Miller Aine · CIK 0002012524 · SVP, DEV & HEAD OF IRE OFFICE

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,261

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
February 20, 2025 Filed Feb 25, 2025 00:26 UTC
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY
Tax withholdingOrdinary Shares 14,534 $9.66 $140,398.44
Disclosure

SEC source: 0001415889-25-005349 · form4-02252025_120247.xml · nonDerivative · entry 1

Grimaud Brett A. · CIK 0001966698 · SVP, GEN COUNSEL AND SECRETARY

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 318,811

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
February 20, 2025 Filed Feb 25, 2025 00:24 UTC
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
Tax withholdingOrdinary Shares 15,810 $9.66 $152,724.60
Disclosure

SEC source: 0001415889-25-005347 · form4-02252025_120248.xml · nonDerivative · entry 2

Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 299,038

F2 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
February 20, 2025 Filed Feb 25, 2025 00:32 UTC
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
Tax withholdingOrdinary Shares 35,129 $9.66 $339,346.14
Disclosure

SEC source: 0001415889-25-005357 · form4-02252025_120241.xml · nonDerivative · entry 1

Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,775,966

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
February 20, 2025 Filed Feb 25, 2025 00:30 UTC
Sawaf AzizSVP & CHIEF FINANCIAL OFFICER
Tax withholdingOrdinary Shares 13,751 $9.66 $132,834.66
Disclosure

SEC source: 0001415889-25-005353 · form4-02252025_120230.xml · nonDerivative · entry 1

Sawaf Aziz · CIK 0001961289 · SVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 299,138

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
February 10, 2025 Filed Feb 25, 2025 00:24 UTC
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
GrantOrdinary Shares 5,283 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-005347 · form4-02252025_120248.xml · nonDerivative · entry 1

Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 314,848

F1 · shares: On April 2, 2024 the reporting person was granted a performance restricted stock unit award that vests based on the achievement of certain performance conditions and continued employment. On February 10, 2025, the performance conditions were deemed achieved as to 5,283 RSUs, and such RSUs became eligible to vest based on the reporting person's continued service.

Read SEC document
January 21, 2025 Filed Jan 23, 2025 23:05 UTC
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
SaleOrdinary Shares 4,000 $9.00 $36,000.00
Disclosure

SEC source: 0001415889-25-001957 · form4-01232025_110129.xml · nonDerivative · entry 1

Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 309,565

Read SEC document
November 20, 2024 Filed Nov 22, 2024 23:08 UTC
Miller AineSVP, DEV & HEAD OF IRE OFFICE
Tax withholdingOrdinary Shares 10,076 $9.97 $100,457.72
Disclosure

SEC source: 0001415889-24-027569 · form4-11222024_111114.xml · nonDerivative · entry 1

Miller Aine · CIK 0002012524 · SVP, DEV & HEAD OF IRE OFFICE

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,556

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
November 20, 2024 Filed Nov 22, 2024 23:06 UTC
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY
Tax withholdingOrdinary Shares 9,268 $9.97 $92,401.96
Disclosure

SEC source: 0001415889-24-027567 · form4-11222024_111140.xml · nonDerivative · entry 1

Grimaud Brett A. · CIK 0001966698 · SVP, GEN COUNSEL AND SECRETARY

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 333,345

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
November 20, 2024 Filed Nov 22, 2024 23:04 UTC
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
Tax withholdingOrdinary Shares 9,178 $9.97 $91,504.66
Disclosure

SEC source: 0001415889-24-027564 · form4-11222024_111143.xml · nonDerivative · entry 1

Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 313,565

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
November 20, 2024 Filed Nov 22, 2024 23:10 UTC
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
Tax withholdingOrdinary Shares 15,997 $9.97 $159,490.09
Disclosure

SEC source: 0001415889-24-027573 · form4-11222024_111145.xml · nonDerivative · entry 1

Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,811,095

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
November 20, 2024 Filed Nov 22, 2024 23:09 UTC
Sawaf AzizSVP & CHIEF FINANCIAL OFFICER
Tax withholdingOrdinary Shares 8,477 $9.97 $84,515.69
Disclosure

SEC source: 0001415889-24-027571 · form4-11222024_111127.xml · nonDerivative · entry 1

Sawaf Aziz · CIK 0001961289 · SVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 312,889

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
November 14, 2024 Filed Nov 20, 2024 02:08 UTC
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
GrantOrdinary Shares 3,193 $9.57 $30,557.01
Disclosure

SEC source: 0001415889-24-027297 · form4-11202024_021133.xml · nonDerivative · entry 1

Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,827,092

F1 · kind: This transaction is being reported late due to inadvertent administrative error. Reflects an acquisition from the Issuer pursuant to a restricted share purchase agreement under the Issuer's Amended and Restated 2013 Equity Incentive Plan at a per-share price equal to the closing per-share price of the Issuer's ordinary shares on the Nasdaq Global Market on November 14, 2024. Transaction was with the Issuer and did not involve an open market transaction.

Read SEC document
November 11, 2024 Filed Nov 14, 2024 01:42 UTC
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
SaleOrdinary Shares 4,000 $9.00 $36,000.00
Disclosure

SEC source: 0001415889-24-026766 · form4-11142024_011103.xml · nonDerivative · entry 1

Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 322,743

Read SEC document
August 20, 2024 Filed Aug 23, 2024 00:06 UTC
Miller AineSVP, DEV & HEAD OF IRE OFFICE
Tax withholdingOrdinary Shares 5,201 $8.22 $42,752.22
Disclosure

SEC source: 0001415889-24-022088 · form4-08232024_120828.xml · nonDerivative · entry 1

Miller Aine · CIK 0002012524 · SVP, DEV & HEAD OF IRE OFFICE

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,632

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
August 20, 2024 Filed Aug 23, 2024 00:05 UTC
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY
Tax withholdingOrdinary Shares 9,268 $8.22 $76,182.96
Disclosure

SEC source: 0001415889-24-022086 · form4-08232024_120857.xml · nonDerivative · entry 1

Grimaud Brett A. · CIK 0001966698 · SVP, GEN COUNSEL AND SECRETARY

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 342,613

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
August 20, 2024 Filed Aug 23, 2024 00:03 UTC
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
Tax withholdingOrdinary Shares 9,222 $8.22 $75,804.84
Disclosure

SEC source: 0001415889-24-022084 · form4-08232024_120835.xml · nonDerivative · entry 1

Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 326,743

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
August 20, 2024 Filed Aug 23, 2024 00:09 UTC
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
Tax withholdingOrdinary Shares 15,997 $8.22 $131,495.34
Disclosure

SEC source: 0001415889-24-022092 · form4-08232024_120807.xml · nonDerivative · entry 1

Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,823,899

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
August 20, 2024 Filed Aug 23, 2024 00:07 UTC
Sawaf AzizSVP & CHIEF FINANCIAL OFFICER
Tax withholdingOrdinary Shares 8,635 $8.22 $70,979.70
Disclosure

SEC source: 0001415889-24-022090 · form4-08232024_120846.xml · nonDerivative · entry 1

Sawaf Aziz · CIK 0001961289 · SVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 321,366

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
August 07, 2024 Filed Aug 9, 2024 22:02 UTC
Samaha Eli10% owner
PurchaseCOM 999,800 $7.80 $7,798,440.00
Disclosure

SEC source: 0001877589-24-000006 · primary_doc.xml · nonDerivative · entry 1

Samaha Eli · CIK 0001877589 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 9,511,150

F1 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities.

Read SEC document
August 07, 2024 Filed Aug 9, 2024 22:05 UTC
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
GrantOrdinary Shares 3,252 $7.83 $25,463.16
Disclosure

SEC source: 0001415889-24-021057 · form4-08092024_100810.xml · nonDerivative · entry 1

Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,839,896

F1 · kind: Reflects an acquisition from the Issuer pursuant to a restricted share purchase agreement under the Issuer's Amended and Restated 2013 Equity Incentive Plan at a per-share price equal to the closing per-share price of the Issuer's ordinary shares on the Nasdaq Global Market on August 7, 2024. Transaction was with the Issuer and did not involve an open market transaction.

Read SEC document
July 10, 2024 Filed Jul 12, 2024 22:15 UTC
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
SaleOrdinary Shares 4,000 $9.00 $36,000.00
Disclosure

SEC source: 0001415889-24-019534 · form4-07122024_100709.xml · nonDerivative · entry 1

Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 335,965

F1 · shares: This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 03/14/2024.

Read SEC document
May 20, 2024 Filed May 22, 2024 22:06 UTC
Miller AineSVP, DEV & HEAD OF IRE OFFICE
Tax withholdingOrdinary Shares 5,201 $9.10 $47,329.10
Disclosure

SEC source: 0001415889-24-014137 · form4-05222024_100521.xml · nonDerivative · entry 1

Miller Aine · CIK 0002012524 · SVP, DEV & HEAD OF IRE OFFICE

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 165,833

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
May 20, 2024 Filed May 22, 2024 22:04 UTC
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY
Tax withholdingOrdinary Shares 9,268 $9.10 $84,338.80
Disclosure

SEC source: 0001415889-24-014135 · form4-05222024_100547.xml · nonDerivative · entry 1

Grimaud Brett A. · CIK 0001966698 · SVP, GEN COUNSEL AND SECRETARY

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 351,881

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

F2 · balance_after: Includes 465 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2024.

Read SEC document
May 20, 2024 Filed May 22, 2024 22:02 UTC
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
Tax withholdingOrdinary Shares 9,268 $9.10 $84,338.80
Disclosure

SEC source: 0001415889-24-014133 · form4-05222024_100547.xml · nonDerivative · entry 1

Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 339,965

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
May 20, 2024 Filed May 22, 2024 22:10 UTC
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
Tax withholdingOrdinary Shares 15,997 $9.10 $145,572.70
Disclosure

SEC source: 0001415889-24-014141 · form4-05222024_100514.xml · nonDerivative · entry 1

Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,836,644

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
May 20, 2024 Filed May 22, 2024 22:08 UTC
Sawaf AzizSVP & CHIEF FINANCIAL OFFICER
Tax withholdingOrdinary Shares 8,635 $9.10 $78,578.50
Disclosure

SEC source: 0001415889-24-014139 · form4-05222024_100507.xml · nonDerivative · entry 1

Sawaf Aziz · CIK 0001961289 · SVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 330,001

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
May 15, 2024 Filed May 17, 2024 22:01 UTC
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
GrantOrdinary Shares 2,068 $9.85 $20,369.80
Disclosure

SEC source: 0001415889-24-013612 · form4-05172024_100519.xml · nonDerivative · entry 1

Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,852,641

F1 · kind: Reflects an acquisition from the Issuer pursuant to a restricted share purchase agreement under the Issuer's Amended and Restated 2013 Equity Incentive Plan at a per-share price equal to the closing per-share price of the Issuer's ordinary shares on the Nasdaq Global Market on May 15, 2024. Transaction was with the Issuer and did not involve an open market transaction.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.